Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol RBCK1 contributors: mct/npt/pgu - updated : 27-06-2017
HGNC name RanBP-type and C3HC4-type zinc finger containing 1
HGNC id 15864
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • an N-terminal region containing Leu-142 and Leu-145 serving as the nuclear export
  • an ubiquitin like domain, required for the binding to RNF31 to assemble LUBAC, and interacting with the Phe4-centered patch of the proximal UBC
  • two coiled-coil regions
  • a RING finger
  • a B-box, and a B-box-like motif
  • a Npl4 zinc finger (NZF) domain specifically binds linear polyubiquitin chains and determined the crystal structure of the RBCK1 NZF domain in complex with linear diubiquitin
  • a C-terminal one containing the RING-IBR domain, serving as localization signals
  • conjugated PhosphoP , MetalloP
    mono polymer homomer , dimer
    HOMOLOGY
    interspecies homolog to rattus Pkcbpb15
    ortholog to murine AL033326
    Homologene
    FAMILY
  • RING finger proteins family
  • CATEGORY enzyme
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm,organelle,lumen
    intracellular,cytoplasm,cytosolic
    intracellular,nucleus,nucleoplasm,nuclear bodies
    text shuttle between the nucleus and cytoplasm
    basic FUNCTION
  • acting as a E3 ubiquitin protein ligase
  • involved in transcriptional machinery in the nuclear bodies, and its transcriptional activity is regulated by nucleocytoplasmic shuttling
  • function as a transcriptional activator whose nuclear translocation is prevented by interaction with the cytoplasmic RBCK2
  • possessed a transcriptional activity, shuttling between the cytoplasm and nucleus, has also been found to exhibit a significant ubiquinating activity, which is inhibited by interaction with its splice variant RBCK2 or phosphorylation by PKC beta
  • is not required for iron-dependent degradation of IREB2 in most cell types
  • function as a transcriptional activator whose nuclear translocation is prevented by interaction with the cytoplasmic RBCK2
  • regulates cell cycle progression and proliferation of ERalpha-positive breast cancer cells by supporting transcription of ERalpha and cyclin B1
  • may be unique in its mechanism of interaction with linear chains
  • is likely important for the ubiquitination of NR1I2 and may play a role in its proteasomal degradation
  • CELLULAR PROCESS nucleotide, transcription, regulation
    protein, ubiquitin dependent proteolysis
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule metal binding,
  • Zn2+
  • protein
  • binding to PRKCB1, PRKCZ, UBE2L3, X protein of hepatite B virus, IRP2
  • interact with nuclear body proteins, CREB-binding protein (CBP), and promyelocytic leukemia protein (PML)
  • binds to a unique 73-AAs domain in IREB2 in an iron-dependent manner to regulate IREB2 polyubiquitylation and degradation
  • protein kinase C (PKC) beta- and zeta-interacting protein
  • with SHARPIN are novel interaction partners of EYA1, and are coexpressed with EYA1 in several organs during craniofacial embryogenesis
  • SHARPIN activates NFKB1 signaling by forming a linear ubiquitin chain assembly complex with RNF31 (HOIP) and RBCK1 (HOIL1)
  • specific interaction between the RBCK1L NZF domain and linear chains is important for NFKB1 activation
  • ESR1 regulation of its own mRNA expression is facilitated by RBCK1 recruitment, suggesting an ESR1 coactivator function of RBCK1
  • RBCK1 ubiquitinates NR1I2, and this may target NR1I2 for degradation by the ubiquitin-proteasome pathway
  • co operates with the E3 ubiquitin ligase RNF31 to modify specific NFKB1 signaling proteins with linear M1-linked polyubiquitin chains
  • MALT1-mediated RBCK1 cleavage provides a gain-of-function mechanism that is involved in the negative feedback regulation of NFKB1 signaling
  • is a negative regulator of lymphocyte activation cleaved by MALT1
  • HOXA1 binds RBCK1 and TRAF2 and modulates the TNF/NFKB1 pathway in a transcription-independent manner
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s) PGBM1
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional     --over  
    mediates the development of myocyte hypertrophy, and promotes cardiac myocyte hypertrophy
    tumoral        
    silencing of RBCK1 impairs lung tumor growth
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    cardiovascularaquiredheart failure
    PRKCB1-RBCK1 interaction would serve as a potential therapeutic target to treat pathological cardiac hypertrophy
    cancer  
    is likely an attractive target for cancer therapy
    ANIMAL & CELL MODELS
  • Hoil-1-deficient mice exhibit amylopectin-like deposits in the myocardium, pathogen-specific immunodeficiency, but minimal signs of hyper-inflammation